OntologiesCurators at RGD make annotations to genes, QTLs and strains using standardized vocabularies/ontologies. Your search returned annotations to the terms below.ChEBI: ChEBI Ontology
1-(beta-D-galactosyl)-N-(9Z-octadecenoyl)-sphingosine
1-(beta-D-galactosyl)-N-[(2R)-2-hydroxylignoceroyl]sphingosine
1-(beta-D-galactosyl)-N-behenoylsphingosine
1-(beta-D-galactosyl)-N-octadecenoylsphingosine
1-(D-galactosyl)-N-(2R)-2-hydroxytetracosenoylsphingosine
1-O-(3-deoxy-alpha-D-galactopyranosyl)-N-hexacosanoylsphinganine
1-O-(4-deoxy-alpha-D-xylo-hexopyranosyl)-N-hexacosanoylphytosphingosine
1-O-(4-deoxy-alpha-D-xylo-hexopyranosyl)-N-hexacosanoylsphinganine
1-O-(4-O-\{3-[4-(trifluoromethyl)phenyl]propyl\}-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine
1-O-(4-O-allyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine
1-O-(4-O-benzyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine
1-O-(4-O-propyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine
1-O-(6-deoxy-6-benzamido-alpha-D-galactopyranosyl)-N-hexacosanoylphytosphingosine
1-O-(6-thio-alpha-D-galactopyranosyl)-N-hexacosanylphytosphingosine
1-O-(alpha-D-galactopyranosyl)-N-hexacosanoylsphinganine
1-O-(alpha-D-galactopyranosyl)-N-icosa-11,14-dienoylphytosphingosine
1-O-(alpha-D-galactopyranosyl)-N-nonanoylphytosphingosine
1-O-(alpha-D-galactopyranosyl)-N-tetracosanyl-2-aminononane-1,3,4-triol
1-O-(alpha-D-galactopyranosyl)-N-tetracosanylphytosphingosine
1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine
1-O-[4-O-(2-adamantylethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine
1-O-[4-O-(3,4-dichlorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine
1-O-[4-O-(3,4-difluorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine
1-O-[4-O-(3-phenylpropyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine
1-O-[4-O-(4-chlorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine
1-O-[4-O-(4-fluorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine
1-O-[4-O-(4-methylbenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine
1-O-[4-O-(4-phenylbutyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine
1-O-[4-O-(4-tert-butylbenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine
1-O-[4-O-(5-phenylpentyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine
1-O-[4-O-(6-phenylhexyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine
1-O-[4-O-(cyclobutylmethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine
1-O-[4-O-(cyclopropylmethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine
1-O-[6-O-(1-naphthylcarbamoyl)-alpha-D-galactopyranosyl]-N-hexacosanoylphytosphingosine
1-O-[6-O-(3-phenylpropanoyl)-alpha-D-galactopyranosyl]-N-hexacosanoylsphinganine
1-O-[6-O-(3-phenylpropanoyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine
1-O-[6-O-(4-pyridylcarbamoyl)-alpha-D-galactopyranosyl]-N-hexacosanoylphytosphingosine
1-O-[alpha-D-galactosyl-(1->2)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine
1-O-\{4-O-[3-(3,4-dichlorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine
1-O-\{4-O-[3-(4-chlorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine
1-O-\{4-O-[3-(4-fluorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine
1-O-\{4-O-[3-(4-methoxyphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine
1-O-\{4-O-[3-(4-methylphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine
1-O-\{4-O-[3-(4-tert-butylphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine
1-O-\{4-O-[4-(trifluoromethyl)benzyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine
1-O-\{6-deoxy-6-[N'-(1-naphthyl)ureido]-alpha-D-galactopyranosyl\}-N-hexacosanoylphytosphingosine
1-O-\{6-O-[(4-chlorophenyl)carbamoyl]-alpha-D-galactopyranosyl\}-N-hexacosanoylphytosphingosine
[4)-alpha-L-Rhap-(1->3)-alpha-D-Galp-(1->2)-alpha-D-Manp-(1->]n
alpha-C(F)-GalCer
alpha-C-GalCer
alpha-D-mannosyl-(1->3)-N-acetyl-alpha-D-galctosaminyl-1-diphospho-ditrans,octacis-undecaprenol(2-)
alpha-L-Fucp-(1->2)-[alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp
alpha-L-Fucp-(1->2)-[alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp
beta-D-galactosyl-(1<->1')-N-(docosanoyl)hexadecasphingosine
beta-D-galactosyl-(1<->1')-N-[(15Z)-tetracosenoyl]sphinganine
beta-D-galactosyl-(1<->1')-N-[(17Z)-hexacosenoyl]sphinganine
beta-D-galactosyl-(1<->1')-N-docosanoyl-(4E,14Z)-sphingadienine
beta-D-galactosyl-(1<->1')-N-docosanoylsphinganine
beta-D-galactosyl-(1<->1')-N-eicosanoylsphinganine
beta-D-galactosyl-(1<->1')-N-henicosanoyl-(4E,14Z)-sphingadienine
beta-D-galactosyl-(1<->1')-N-hexacosanoylsphinganine
beta-D-galactosyl-(1<->1')-N-hexadecanoylsphinganine
beta-D-galactosyl-(1<->1')-N-icosanoyl-(4E,14Z)-sphingadienine
beta-D-galactosyl-(1<->1')-N-octadecanoylsphinganine
beta-D-galactosyl-(1<->1')-N-tetracosanoylsphinganine
beta-D-galactosyl-N-(dodecanoyl)sphingosine
beta-D-galactosyl-N-(hexacosanoyl)sphingosine
beta-D-galactosyl-N-(nervonoyl)sphingosine
beta-D-galactosyl-N-(tetracosanoyl)sphingosine
beta-D-galactosyl-N-(tricosanoyl)sphingosine
beta-D-galactosyl-N-[(15Z)-tetracosenoyl]sphingosine
beta-D-galactosyl-N-[(17Z)-hexacosenoyl]sphingosine
beta-D-galactosyl-N-eicosanoylsphingosine
beta-D-galactosyl-N-octadecanoylsphingosine
beta-D-Galp-(1->2)-beta-D-Glcp-(1->4)-D-Galp
beta-galactosylceramide
galactosylceramide 42:2
N-(docosanoyl)-1-(2',3',4',6'-tetraacetylbeta-D-galactosyl)-3-acetylsphingosine
N-(hexadecanoyl)-beta-D-galactosylsphingosine
N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxyoctadecan-2-yl]hexacosanethioamide
N-acyl-beta-D-galactosylphytosphingosine
N-acyl-beta-D-galactosylsphingosine
N-acyl-D-galactosylsphingosine
N-tetracosenoyl-D-galactosylsphingosine
EFO: Experimental Factor Ontology
galactocerebrosidase
galactocerebrosidase (human)
galactocerebrosidase, signal peptide removed form
galactosylceramidase activity
galactosylceramide sulfotransferase
galactosylceramide sulfotransferase (human)
GALC (human)
Krabbe disease
GO: Molecular Function
galactogen 6-beta-galactosyltransferase activity
galactosylceramidase activity
galactosylceramide sulfotransferase activity
glycolipid transfer activity
HP: Human Phenotype
Elevated urinary sulfatide level
MP: Mammalian Phenotype
abnormal galactosylceramidase level
absent galactosylceramidase
decreased galactosylceramidase level
increased galactosylceramidase level
PW: Pathway Ontology
galactosemia pathway
RDO: RGD Disease Ontology
Krabbe disease
UBERON: Cross-Species Anatomy
myelin
|
|||||||||||||||||||||||||||||||||||||||||||||||||||



















